MedTrace Logo

Lipoprotein Metabolism and Bacterial Lipopolysaccharide in Parkinson's Disease

NCT03937284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2019-05-03

No results posted yet for this study

Summary

Patients with Parkinson's disease (PD) present an impaired intestinal permeability with consequent lipopolysaccharide (LPS) translocation in the systemic circulation. Plasmatic lipoproteins play a key role in the detoxification of LPS.

The investigators aim to study the relationships between lipoprotein chemical composition and plasma LPS circulation in PD.

Conditions

  • Parkinson Disease

Interventions

OTHER

Patients not treated

Sponsors & Collaborators

  • Istituti Clinici di Perfezionamento di Milano

    collaborator OTHER

  • University of Milan

    lead OTHER

Principal Investigators

  • Roberta Cazzola, PhD · University of Milan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-03
Primary Completion
2017-10-20
Completion
2017-10-20

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03937284 on ClinicalTrials.gov